ReWrite is a startup founded by scientist from the Stem Cell Institute Leuven (SCIL). ReWrite embodies the collective enthusiasm and entrepreneurial spirit of a team of dedicated scientists, led by prof. em. Catherine Verfaillie and spearheaded by Dr. FatemehArefe Nami.
Specializing in iPSC generation and genome editing, we provide tailored solutions for scientific research. Our expertise includes reprogramming somatic cells into iPSCs and advanced genetic modifications. This includes CRISPR-based genome editing, such as corrections and insertions of single nucleotide variants (SNVs) and creating gene knock outs/knock ins.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Gaston Geenslaan 1, Leuven,3001,belgium
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.sc-rewrite.com
- Keywords
- Genome editing and iPSC generation.
- HQ
- Leuven
Rewrite Questions
Rewrite's website is http://www.sc-rewrite.com
Rewrite's LinkedIn profile is https://be.linkedin.com/company/sc-rewrite
Rewrite has
3 employees.
View email and phone details for 3
employees at Rewrite.
Rewrite's industry is
Research Services
Rewrite's top competitors are
Argenx,
Elzeard Foundation,
Sciensano,
Geronimo,
Simabs,
Signatur Biosciences,
Medpace,
Adx Neurosciences,
Cellcarta,
Vib.
Rewrite's categories are Research Services
Rewrite's founding year is 2025
